Navigation Links
Healthcare Reform and Green Initiatives Trigger Explosive Growth in UV Disinfection Technologies

VALENCIA, Calif., July 14 /PRNewswire/ -- The healthcare industry is under attack from all sides. The Obama Administration has asked hospitals to give up $155 billion in future Medicare and Medicaid payments to fund healthcare reform, all the while operating and energy costs continue to rise; insurance providers pay later, pay less and demand more; patients are postponing (profitable) elective surgery; and fewer patients maintain adequate insurance coverage to pay for needed care. In the midst of this crisis, Lumalier Corporation, a U.S. manufacturer of advanced Ultraviolet Germicidal Disinfection Equipment, is experiencing unprecedented growth.

"Sales of Tru-D, a Total Room Disinfection Device, have increased over 250% this year," said Chuck Dunn, President and CEO of Lumalier. According to the manufacturer, Tru-D is an advanced, automated, mobile air and surface disinfection device. "Tru-D is more thorough than manual cleaning protocols and is automated to eliminate human error. It reduces chemical usage and provides fast disinfection of surfaces and air in the hospital environment," said Dunn. "Hospitals are able to reduce costs without reducing services and can turn over rooms more efficiently while insuring that new patients enter a clean and healthy environment."

That's good news to Hospital Administrators and Infection Control Practitioners challenged to provide increased patient care and efficient facility usage with ever-shrinking dollars. Independent Tru-D studies presented at the annual APIC conference (Association of Professionals in Infection Control and Epidemiology) were overwhelmingly favorable, verifying the manufacturer's claims, and creating a backlog of interest.

As a result of this growth, Lumalier announced the opening of a new West Coast office in Valencia, California. Katja Auer has been selected as Director of Business Development for Lumalier Corporation, and will manage the West Coast office. "Lumalier is very methodical in seeking out the best and brightest in our field of UV Disinfection. Katja is a highly qualified, respected professional within the UV industry," stated Dunn. "We look forward to the expertise and knowledge she will provide to our organization. She will be a major asset to our clients worldwide."

Ms. Auer holds a Bachelor's Degree in Chemistry from Connecticut State University, Master's Degree in Analytical Chemistry from the University of Arizona and an MBA from the University of LaVerne. She brings a remarkable diversity of experience in technical sales, management, ISO and FDA quality systems, product R&D, and customer support. She is a voting member and secretary of ASHRAE's TC2.9 Technical Committee on UV Air and Surface Disinfection, and is corresponding member and secretary of the ASHRAE SPC-185 Committee for developing methods of test standards for UV.

Lumalier Corporation is a leading manufacturer of UV germicidal air and surface disinfection equipment for healthcare, correctional, educational, government and private sectors. Lumalier produces a full line of UVC products for the commercial HVAC market, providing the key benefits of cleaner, healthier air, reductions in HVAC maintenance costs, and reductions in energy consumption.

Contact: Katja Auer at 818-679-6961;, or visit

This release was issued through eReleases(TM). For more information, visit

SOURCE Lumalier Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
2. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
3. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
4. Dr. Paul Bandt Celebrates 35th Anniversary With Desert Radiologists and a History of Healthcare in Las Vegas
5. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
6. MDS to Present at Thomas Weisel Partners Healthcare Conference
7. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
8. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
9. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
10. Kingfisher Healthcare (KFH) Achieves World Class Quality Platform
11. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
Post Your Comments:
(Date:11/30/2015)... , ... November 30, 2015 , ... According to Los ... people to overeat are not necessarily caused by real hunger, but instead by ... needs food. He notes that, while many patients are aware that weight loss surgery ...
(Date:11/30/2015)... ... November 30, 2015 , ... A record crowd gathered at the ... organized by the Baruch S. Blumberg Institute. , The institute, which is the research ... science and biotechnology leaders for the conference, which focused on ways companies can work ...
(Date:11/30/2015)... ... November 30, 2015 , ... A novel class of antimicrobials ... effective in fighting methicillin-resistant Staphylococcus aureus (MRSA), one of the major drug-resistant bacterial ... small molecule analogs that target the functions of SecA, a central part of ...
(Date:11/30/2015)... NJ (PRWEB) , ... November 30, 2015 , ... ... top choice for innovative, patient centered orthopedic care. Led by John Vitolo, ... your injury or chronic condition, the team at Advocare Orthopedic & Sports Medicine ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... specializes in general dentistry out of Glen Ridge, NJ. He has both ... to achieve optimal mastication. He is also an expert in cosmetic dentistry. ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... 30, 2015 Diplomat Pharmacy, Inc. (NYSE: ... the Detroit Free Press as a Top Workplace , ... to work for in 2015. ... 100 winners annually, based on employee surveys rating company leadership, ... Workplaces are based solely on employee feedback. The survey is ...
(Date:11/30/2015)... , Nov. 30, 2015  IBA Molecular North America, ... distribution of radiopharmaceuticals, announced that as of January 1, ... (Zevacor Pharma). The decision to rebrand the company reflects ... as well as its close relationship with Zevacor Molecular.  ... Health and Science (IHS). Peter Burke ...
(Date:11/30/2015)... 30, 2015 Baxalta Incorporated (NYSE: ... dedicated to delivering transformative therapies to patients ... today announced the launch and first shipments ... extended circulating half-life recombinant factor VIII (rFVIII) ... ADVATE [Antihemophilic Factor (Recombinant)]. The treatment was ...
Breaking Medicine Technology: